Literature DB >> 24513588

Empirically establishing blood glucose targets to achieve HbA1c goals.

Nancy Wei1, Hui Zheng, David M Nathan.   

Abstract

OBJECTIVE To determine the average fasting, postprandial, and bedtime self-monitored blood glucose (SMBG) concentrations associated with specified HbA1c levels using data from the A1c-Derived Average Glucose (ADAG) study. RESEARCH DESIGN AND METHODS The ADAG study was a multicenter observational study that used continuous glucose monitoring and SMBG testing to determine the relationship between mean average glucose and HbA1c. We used the SMBG data from 470 of the ADAG study participants (237 with type 1 diabetes and 147 with type 2 diabetes) to determine the average fasting, premeal, 90-min postmeal, and bedtime blood glucose (BG) for predefined target HbA1c groups between 5.5 and 8.5% (37-69 mmol/mol). t Tests were used to compare mean BG values between type 1 and type 2 diabetes groups. RESULTS The average fasting BG needed to achieve predefined HbA1c target levels of 5.5-6.49% (37-47 mmol/mol), 6.5-6.99% (48-52 mmol/mol), 7.0-7.49% (52-58 mmol/mol), 7.5-7.99% (58-64 mmol/mol), and 8.0-8.5% (64-69 mmol/mol) were 122 mg/dL with 95% CI 117-127, 142 mg/dL (135-150), 152 mg/dL (143-162), 167 mg/dL (157-177), and 178 mg/dL (164-192), respectively. Postmeal BG to achieve the HbA1c level of 6.5-6.99% (48-52 mmol/mol) and 7.0-7.49% (52-58 mmol/mol) were 139 mg/dL (134-144) and 152 mg/dL (147-157), respectively. Bedtime BG was 153 mg/dL (145-161) and 177 mg/dL (166-188), respectively. CONCLUSIONS We have determined the average BG at premeal, postmeal, and bedtime to achieve a variety of HbA1c targets. These results, based on empirical data, will help patients and providers set realistic day-to-day SMBG targets to achieve individualized HbA1c goals.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24513588      PMCID: PMC3964488          DOI: 10.2337/dc13-2173

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  6 in total

1.  Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Eberhard Standl; Małgorzata Bartnik; Greet Van den Berghe; John Betteridge; Menko-Jan de Boer; Francesco Cosentino; Bengt Jönsson; Markku Laakso; Klas Malmberg; Silvia Priori; Jan Ostergren; Jaakko Tuomilehto; Inga Thrainsdottir; Ilse Vanhorebeek; Marco Stramba-Badiale; Peter Lindgren; Qing Qiao; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; John Camm; Veronica Dean; Jaap Deckers; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; Juan Tamargo; José Luis Zamorano; Jaap W Deckers; Michel Bertrand; Bernard Charbonnel; Erland Erdmann; Ele Ferrannini; Allan Flyvbjerg; Helmut Gohlke; Jose Ramon Gonzalez Juanatey; Ian Graham; Pedro Filipe Monteiro; Klaus Parhofer; Kalevi Pyörälä; Itamar Raz; Guntram Schernthaner; Massimo Volpe; David Wood
Journal:  Eur Heart J       Date:  2007-01       Impact factor: 29.983

2.  American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan.

Authors:  Yehuda Handelsman; Jeffrey I Mechanick; Lawrence Blonde; George Grunberger; Zachary T Bloomgarden; George A Bray; Samuel Dagogo-Jack; Jaime A Davidson; Daniel Einhorn; Om Ganda; Alan J Garber; Irl B Hirsch; Edward S Horton; Faramarz Ismail-Beigi; Paul S Jellinger; Kenneth L Jones; Lois Jovanovič; Harold Lebovitz; Philip Levy; Etie S Moghissi; Eric A Orzeck; Aaron I Vinik; Kathleen L Wyne
Journal:  Endocr Pract       Date:  2011 Mar-Apr       Impact factor: 3.443

3.  Standards of medical care in diabetes--2013.

Authors: 
Journal:  Diabetes Care       Date:  2013-01       Impact factor: 19.112

Review 4.  Long-term complications of diabetes mellitus.

Authors:  D M Nathan
Journal:  N Engl J Med       Date:  1993-06-10       Impact factor: 91.245

Review 5.  Standards of care for diabetes.

Authors:  G C Weir; D M Nathan; D E Singer
Journal:  Diabetes Care       Date:  1994-12       Impact factor: 19.112

6.  Translating the A1C assay into estimated average glucose values.

Authors:  David M Nathan; Judith Kuenen; Rikke Borg; Hui Zheng; David Schoenfeld; Robert J Heine
Journal:  Diabetes Care       Date:  2008-06-07       Impact factor: 19.112

  6 in total
  23 in total

1.  ADAG study group data links A1C levels with empirically measured blood glucose values - new treatment guidelines will now be needed.

Authors:  David C Klonoff
Journal:  J Diabetes Sci Technol       Date:  2014-04-30

2.  Use of Color Range Indicator Technology on Point-of-Care Meters May Ease Self-Management of Blood Glucose.

Authors:  Marc C Torjman
Journal:  J Diabetes Sci Technol       Date:  2016-11-01

3.  Remote Health Consultations Supported by a Diabetes Management Web Application With a New Glucose Meter Demonstrates Improved Glycemic Control.

Authors:  Mike Grady; Hilary Cameron; Brian L Levy; Laurence B Katz
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

4.  A case of inappropriately high glycated hemoglobin.

Authors:  Moushumi Lodh; Rajarshi Mukhopadhyay; Balwant Kumar
Journal:  Indian J Clin Biochem       Date:  2014-10-10

5.  Interactive Exposure With a Blood Glucose Monitor With a Novel Glucose Color Range Indicator Is Associated With Improved Glucose Range Interpretation and Awareness in Patients With Type 2 Diabetes.

Authors:  Mike Grady; Graham Warren; Brian L Levy; Laurence B Katz
Journal:  J Diabetes Sci Technol       Date:  2015-02-03

6.  US Emergency Department Visits Attributed to Medication Harms, 2017-2019.

Authors:  Daniel S Budnitz; Nadine Shehab; Maribeth C Lovegrove; Andrew I Geller; Jennifer N Lind; Daniel A Pollock
Journal:  JAMA       Date:  2021-10-05       Impact factor: 56.272

7.  The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults.

Authors:  David Flood; Jacqueline A Seiglie; Matthew Dunn; Scott Tschida; Michaela Theilmann; Maja E Marcus; Garry Brian; Bolormaa Norov; Mary T Mayige; Mongal Singh Gurung; Krishna K Aryal; Demetre Labadarios; Maria Dorobantu; Bahendeka K Silver; Pascal Bovet; Jutta M Adelin Jorgensen; David Guwatudde; Corine Houehanou; Glennis Andall-Brereton; Sarah Quesnel-Crooks; Lela Sturua; Farshad Farzadfar; Sahar Saeedi Moghaddam; Rifat Atun; Sebastian Vollmer; Till W Bärnighausen; Justine I Davies; Deborah J Wexler; Pascal Geldsetzer; Peter Rohloff; Manuel Ramírez-Zea; Michele Heisler; Jennifer Manne-Goehler
Journal:  Lancet Healthy Longev       Date:  2021-05-21

8.  Neutrophil-to-lymphocyte ratio and red blood cell distribution width as predictors of microalbuminuria in type 2 diabetes.

Authors:  Tikva Assulyn; Rola Khamisy-Farah; William Nseir; Amir Bashkin; Raymond Farah
Journal:  J Clin Lab Anal       Date:  2020-02-25       Impact factor: 2.352

9.  Fasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011).

Authors:  Sangmo Hong; Jun Goo Kang; Chul Sik Kim; Seong Jin Lee; Chang Beom Lee; Sung-Hee Ihm
Journal:  Diabetol Metab Syndr       Date:  2016-08-30       Impact factor: 3.320

Review 10.  Expert Group Recommendations on the Effective Use of Bolus Insulin in the Management of Type 2 Diabetes Mellitus.

Authors:  Rajeev Chawla; Jagat Jyoti Mukherjee; Manoj Chawla; Alok Kanungo; Meenakshi Sundaram Shunmugavelu; Ashok Kumar Das
Journal:  Med Sci (Basel)       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.